NCT01323673View on ClinicalTrials.gov

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

PHASE4CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

November 15, 2010

Primary Completion Date

March 1, 2011

Study Completion Date

March 29, 2011

Conditions
Dermatitis, Chronic
Interventions
DRUG

clobetasol propionate 0.05%

2 times a day, 14 total days study treatment

DRUG

Vehicle / Placebo

2 times a day, 14 total days of study treatment

Trial Locations (10)

33401

GSK Investigational Site, West Palm Beach

33437

GSK Investigational Site, Boynton Beach

37215

GSK Investigational Site, Nashville

37922

GSK Investigational Site, Knoxville

40202

GSK Investigational Site, Louisville

40217

GSK Investigational Site, Louisville

78759

GSK Investigational Site, Austin

92123

GSK Investigational Site, San Diego

07109

GSK Investigational Site, Belleville

07042

GSK Investigational Site, Montclair

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY

NCT01323673 - Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. | Biotech Hunter | Biotech Hunter